COVID vaccines: How to make sense of reports on their effectiveness
Real-world trials come with some problems: The target of vaccination, what time it was rolled out and emerging variants
Fillip, more funds for disease surveillance in Union Budget 2021-22
Pradhan Mantri AtmaNirbhar Swasth Bharat Yojana will help improve detection and treatment of new diseases but not fortify the overall health …
Wary healthcare workers in Assam inoculated with COVID-19 vaccines
Beneficiaries January 16, especially expressed wariness about Covaxin, compared to Covishield
Delaying the second COVID-19 vaccine dose: A medical expert answers key questions
The uncertainty is around how long the protective effect of the first dose will last without a second shot
Early human trial of COVID-19 vaccine gives positive results
Developed by Beijing-based firm, the vaccine shows development of both forms of immunity
Ebola emergency: WHO spotlight on experimental drugs
On Friday, it was disclosed that three persons in New Delhi are being kept under watch for possible Ebola symptoms
COVID-19 was declared a pandemic 4 years ago: Take a look at the virus’ journey and global response to it
A timeline of the key events related to COVID-19
Lateral Thoughts: Waiting for the vaccine?
Vaccination programmes cannot be dealt with outside the purview of public health
Coronavirus update: 157 new cases in the country; Drills at hospitals to check preparedness
India now has 3,421 active cases; Cumulative vaccinations cross 2,200 million
Lumpy disease: 35,000 cattle killed in 9 states
Multiplication of vectors, stray cattle main reasons behind spread
Millions of doses set to expire by September as India’s COVID-19 vaccination drive stagnates
Share of population completely vaccinated grew just 5 percentage points since April
As told to Parliament (August 10, 2021): A third of India’s coastline under erosion
All that was discussed in the Houses through the day
Is WHO nod for China’s Sinovac a domino effect of COVID-19 second wave in India?
The process of approval has become slower since Pfizer and BioNTech received approval
COVID-19 update: Amid spike in cases, Maharashtra warns of a second wave
Punjab a cause of worry for a high death rate; Kerala continues to see spike in cases
The top scientific breakthrough for 2020 was understanding SARS-CoV-2 and how it causes COVID-19 – and then developing multiple vaccines
History will record this time as one of the greatest periods for scientific advancements
‘COVID-19 wave not distinct entity, will come periodically’
Epidemiologist Dr Chandrakant Lahariya on the new variant, vaccine immunity and India’s preparedness
Scientists identify new route to tackle TB
Researchers analysed the genome of Mycobacterium tuberculosis and identified three G-quadruplex motifs that could be used as drug targets
We're developing the world's first vaccine suitable for humans and livestock
The technique uses a chimpanzee respiratory virus (adenovirus) to expose individuals to just a small part of the Rift Valley Fever virus
Greater trust in government, people could have reduced COVID-19 caseload, fatality rate: Study
Less corrupt government resulted in more widespread, efficient COVID-19 vaccine coverage in some countries
A week of arrogance and distrust
An interdependent world can’t be an inequitable world. We are seriously off track on many counts, writes Sunita Narain
Everyone DOESN’T need booster jabs of COVID-19 vaccines: Lancet study (but are the rich countries reading?)
Access to vaccination has been vastly inequal; Booster doses in developed countries will further squeeze out low, mid-income …
Does my child have separation anxiety? How parents can help with children’s back-to-school fears
Some children experiencing separation anxiety have physical symptoms such as stomach aches and nightmares
Stop boosters now: WHO to rich countries on COVID-19 vaccines
Less than 1% of the population in Democratic Republic of Congo, Uganda, Nigeria, Somalia have been fully vaccinated due to supply shortage
COVID-19 vaccines for all: Why COVAX is not working
The initiative to deliver COVID-19 vaccines to the poorest countries has not succeeded in its goal so far due to over-dependence on a few …
Can vaccines become as cheap as generics?
Unlike with drugs, freeing up patents will not make it any easier to manufacture vaccines for COVID-19, says Cipla’s Hamied